Comment on American Diabetes Association
In the recent STEP HFpEF DM trial, which studied the efficacy of semaglutide among patients with obesity-related HF with preserved ejection fraction (HFpEF) and T2D, a reduction in the time to first HF events was demonstrated in the intervention arm, but this was a secondary endpoint
Ben Lynch explained in this podcast, those with gene mutations and impaired methylation have a higher chance of deficiency as these methylation nutrients are needed for glutathione production
Recent studies have highlighted the central role of the liver in the peripheral clearance of A, along with significant roles played by the kidneys and other peripheral organs
And this is true whether or not youre taking a GLP-1
14 mg dose After at least 30 days taking the 7 mg dose, your healthcare professional may prescribe the 14 mg dose if more blood sugar control is needed